The Growth Opportunity Fund will provide liquidity to existing tech company investors.
But local cryogenics company Fabrum says Govt support is needed to kickstart the opportunity posed by Australia’s AMSL Aero.
The cancer therapy company has raised $15m in a Series A round, ahead of a future ASX listing.
Startup’s founders create a Kiwi-owned alternative to the Big Four banks and foreign neo-bank disruptors.
It has opened a new $4m sterile filtration plant in Uruguay’s free trade zone.
Iranian-born brothers Masood and Massih Tayebi set up a New Zealand arm of their investment company Bridgewest Group a decade ago.
Reynolds has won the top accolade at the annual KiwiNet research commercialisation awards. Other winners include a new potato variety and an IP guru.
The NZ-founded but US-based medical technology startup uses AI-powered software to screen the eye for cardiovascular and kidney disease.
Head of the country’s largest tech company says it’s a question of when rather than if AI stocks will be re-rated.
Soul Capital CEO Jamie Newth calls the exit a ‘case study in impact venture capital’, as the company expands its AI ocean security tech into North America, Europe and the Indo-Pacific.